Introduction: Determination of antinuclear antibodies (ANA) by indirect immunofluorescence (IIF) is usually the initial test for the diagnosis of systemic rheumatic diseases (SRD). The gene discussed is BTG3; the disease is dopa-responsive dystonia due to sepiapterin reductase deficiency.